1 Environmental Microbiology and Biotechnology Laboratory, Department of Microbiology, University of Ibadan, Ibadan, Nigeria.
2 Molecular Biology and Biotechnology Laboratory, Department of Microbiology, University of Ibadan, Ibadan, Nigeria.
Acta Microbiol Immunol Hung. 2022 Jun 8;69(2):127-134. doi: 10.1556/030.2022.01747. Print 2022 Jun 16.
Infections of the urinary tract have been on the rise globally and these are also worsened by the increasing rate of antibiotic resistance in uropathogens. This study aimed to determine the susceptibility profile of extended spectrum β-lactamase (ESBL)- producing uropathogens to selected antibiotics and their carriage of ESBL genes. Bacterial uropathogens were obtained from the urine bench of a Microbiology laboratory in a Teaching Hospital in South-West Nigeria. Susceptibility to antibiotics was tested using the disc diffusion method, while detection of ESBL production was done using the double disc synergy test (DDST). Detection of ESBL genes was performed by PCR. A total of 21 ESBL- producing uropathogens were obtained namely: Klebsiella pneumoniae (11), Klebsiella oxytoca (6), Proteus mirabilis (2), Enterobacter cloacae (1) and Pseudomonas aeruginosa (1). The resistance to antibiotics in the uropathogens was: imipenem (0%), gentamicin (38.1%), sulfamethoxazole-trimethoprim (52.4%), amoxicillin-clavulanate (61.9%), aztreonam (66.7%), ceftazidime (66.7%), tetracycline (90.5%), cefpodoxime (100%) and cefotaxime (100%). Altogether, 90.5% (19/21) of the isolates were multidrug resistant (MDR). Of the 21 uropathogens, 61.9% (13/21) carried bla CTX-M, 52.4% (11/21) carried bla TEM while bla SHV was detected in 47.6% (10/21) of the isolates. There was co-carriage of ESBL genes in 12 uropathogens. This study showed a high prevalence of multidrug resistance and a high carriage of ESBL genes in the ESBL- producing isolates obtained over the study period. There is a need for a review of antibiotic options in the treatment of UTI to clamp down on the ever-increasing tide of antibiotic resistance in uropathogens.
尿路感染在全球呈上升趋势,而尿路病原体对抗生素的耐药率不断上升,使情况进一步恶化。本研究旨在确定产超广谱β-内酰胺酶(ESBL)的尿路病原体对选定抗生素的敏感性,并检测其携带 ESBL 基因的情况。细菌尿路病原体是从尼日利亚西南部一家教学医院微生物实验室的尿液工作台获得的。使用纸片扩散法检测抗生素敏感性,使用双纸片协同试验(DDST)检测 ESBL 产生情况,使用 PCR 检测 ESBL 基因。共获得 21 株产 ESBL 的尿路病原体,分别为肺炎克雷伯菌(11 株)、产酸克雷伯菌(6 株)、奇异变形杆菌(2 株)、阴沟肠杆菌(1 株)和铜绿假单胞菌(1 株)。尿路病原体对抗生素的耐药性如下:亚胺培南(0%)、庆大霉素(38.1%)、复方磺胺甲噁唑(52.4%)、阿莫西林克拉维酸(61.9%)、氨曲南(66.7%)、头孢他啶(66.7%)、四环素(90.5%)、头孢泊肟(100%)和头孢噻肟(100%)。总共,19/21(90.5%)株为多重耐药(MDR)。在 21 株尿路病原体中,61.9%(13/21)携带 bla CTX-M,52.4%(11/21)携带 bla TEM,而 bla SHV 则在 47.6%(10/21)株中被检测到。12 株尿路病原体同时携带 ESBL 基因。本研究表明,在所研究期间获得的产 ESBL 分离株中,MDR 的发生率很高,且携带 ESBL 基因的比例也很高。需要重新评估 UTI 治疗中抗生素的选择,以遏制尿路病原体对抗生素耐药性的不断上升。